Tesla (TSLA) reports 336,681 vehicle deliveries for Q1 2025
Tesla (NASDAQ:TSLA) has released its first quarter 2025 vehicle delivery and production report.
The report was published on the company’s Investor Relations website.
Q1 2025 Deliveries
In the first quarter, Tesla delivered a total of 336,681 vehicles globally. This is comprised of 323,800 Model 3 and Model Y, as well as 12,881 units of Tesla’s other models.
In comparison, Tesla’s company-compiled consensus indicated that analysts were expecting 377,592 vehicle deliveries for Q1 2025. FactSet estimates were even more optimistic, with analysts expecting vehicle deliveries of 407,900 units in the first quarter.

Q1 2025 Production
Tesla produced a total of 362,615 vehicles in the first quarter across its factories globally. From this number, a total of 345,454 units were comprised of the Model 3 and Model Y, and 17,161 were comprised of the company’s other models.
In its Q1 2025 vehicle production and delivery report, Tesla noted that the changeover of its Model Y lines across Gigafactory Texas, Fremont Factory, Gigafactory Shanghai, and Gigafactory Berlin, led to the loss of several weeks’ worth of production in the quarter. The vehicle, however, is now being ramped.
TSLA Reaction
While Tesla missed analysts’ expectations, investors do not seem to be too disappointed. As per writing, TSLA stock is just down 1.87% at $263.43 per share.
The post Tesla (TSLA) reports 336,681 vehicle deliveries for Q1 2025 appeared first on TESLARATI.
Source: https://www.teslarati.com/tesla-tsla-q1-2025-vehicle-deliveries-production-report/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
